CYTOKINETICS INC
CYTKNASDAQ🏆 #930 by market capEarnings Oct 29US Equity
$65.64▼ $0.52 (−0.79%)
🌙 After hours$65.90▲ 0.40%Regular close · extended-hours price shownTrack CYTK
Get earnings, price moves & breaking news on Telegram
24h▼ 0.8%
7d▼ 0.3%
14d▼ 5.4%
30d▼ 7.4%
ytd▲ 3.3%
1y▲ 19.4%
🏦Market Cap
$8.90B
Small Cap
📈Revenue Growth (YoY)
-21.1%
Declining
📊Gross Margin
—
💵FCF Margin
84.8%
Strong
⚖️P/S Ratio
135.1x
Expensive
Otter Score
60
Fair
CYTOKINETICS INC
CYTKAnalyst Ratings
Price
$65.64
Total
35
Raised
3
Lowered
0
Avg PT
$112.50
H / L
$140 / $95
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-08-31 | — | — |
Barclays | Reiterated | Overweight | 2026-08-13 | $110.00 | +67.60% |
JP Morgan | Reiterated | Overweight | 2026-08-13 | — | — |
Truist Securities | Reiterated | Buy | 2026-08-10 | — | — |
Citizens | Reiterated | Market Outperform | 2026-08-07 | — | — |
Needham | Reiterated | Buy | 2026-08-07 | $112.00 | +70.60% |
RBC Capital | Reiterated | Outperform | 2026-08-07 | $112.00 | +70.60% |
UBS | Upgraded | Neutral → Buy | 2026-06-29 | $115.00 | +75.20% |
Mizuho | Reiterated | Outperform | 2026-06-24 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-05-07 | $95.00 | +44.70% |
Stifel | Reiterated | Buy | 2026-05-06 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-05-06 | $103.00 | +56.90% |
Leerink Partners | Reiterated | Outperform | 2026-02-26 | $83.00 | +26.40% |
B. Riley Securities | Reiterated | Buy | 2026-01-21 | — | — |
Goldman Sachs | Upgraded | Neutral → Buy | 2025-12-19 | $99.00 | +50.80% |
B of A Securities | Reiterated | Neutral | 2025-10-02 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2025-09-03 | — | — |
Citigroup | Reiterated | Buy | 2025-09-02 | — | — |
JMP Securities | Reiterated | Market Outperform | 2025-09-02 | $78.00 | +18.80% |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-04-03 | — | — |
Raymond James | Reiterated | Outperform | 2024-05-23 | $63.00 | −4.00% |
Oppenheimer | Reiterated | Outperform | 2024-05-09 | $106.00 | +61.50% |
Cantor Fitzgerald | Reiterated | Overweight | 2023-10-09 | — | — |
Piper Sandler | Reiterated | Overweight | 2022-06-10 | $107.00 | +63.00% |
Jefferies | Reiterated | Buy | 2021-10-07 | $90.00 | +37.10% |
Wolfe Research | Reiterated | Outperform | 2021-03-12 | — | — |
H.C. Wainwright | Reiterated | Buy | 2018-10-05 | $140.00 | +113.30% |
Seaport Global | Reiterated | Buy | 2017-10-06 | — | — |
Rodman & Renshaw | Reiterated | Buy | 2017-03-08 | — | — |
Cowen & Co. | Reiterated | Outperform | 2015-07-15 | — | — |
PiperJaffray | Reiterated | Overweight | 2015-02-13 | — | — |
MLV & Co. | Upgraded | Hold → Buy | 2014-11-04 | — | — |
Leerink Swann | Reiterated | Outperform | 2014-05-19 | — | — |
Roth Capital | Reiterated | Buy | 2014-03-05 | — | — |
Dawson James | Reiterated | Market Outperform → Outperform | 2012-11-27 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-08-31
—
—
Barclays
Reiterated · Overweight · 2026-08-13
$110.00
+67.60%
JP Morgan
Reiterated · Overweight · 2026-08-13
—
—
Truist Securities
Reiterated · Buy · 2026-08-10
—
—
Citizens
Reiterated · Market Outperform · 2026-08-07
—
—
Needham
Reiterated · Buy · 2026-08-07
$112.00
+70.60%
RBC Capital
Reiterated · Outperform · 2026-08-07
$112.00
+70.60%
UBS
Upgraded · Neutral → Buy · 2026-06-29
$115.00
+75.20%
Mizuho
Reiterated · Outperform · 2026-06-24
—
—
Wells Fargo
Reiterated · Overweight · 2026-05-07
$95.00
+44.70%
Stifel
Reiterated · Buy · 2026-05-06
—
—
Morgan Stanley
Reiterated · Overweight · 2026-05-06
$103.00
+56.90%
Leerink Partners
Reiterated · Outperform · 2026-02-26
$83.00
+26.40%
B. Riley Securities
Reiterated · Buy · 2026-01-21
—
—
Goldman Sachs
Upgraded · Neutral → Buy · 2025-12-19
$99.00
+50.80%
B of A Securities
Reiterated · Neutral · 2025-10-02
—
—
Evercore ISI Group
Reiterated · Outperform · 2025-09-03
—
—
Citigroup
Reiterated · Buy · 2025-09-02
—
—
JMP Securities
Reiterated · Market Outperform · 2025-09-02
$78.00
+18.80%
Citizens Capital Markets
Reiterated · Market Outperform · 2025-04-03
—
—
Raymond James
Reiterated · Outperform · 2024-05-23
$63.00
−4.00%
Oppenheimer
Reiterated · Outperform · 2024-05-09
$106.00
+61.50%
Cantor Fitzgerald
Reiterated · Overweight · 2023-10-09
—
—
Piper Sandler
Reiterated · Overweight · 2022-06-10
$107.00
+63.00%
Jefferies
Reiterated · Buy · 2021-10-07
$90.00
+37.10%
Wolfe Research
Reiterated · Outperform · 2021-03-12
—
—
H.C. Wainwright
Reiterated · Buy · 2018-10-05
$140.00
+113.30%
Seaport Global
Reiterated · Buy · 2017-10-06
—
—
Rodman & Renshaw
Reiterated · Buy · 2017-03-08
—
—
Cowen & Co.
Reiterated · Outperform · 2015-07-15
—
—
PiperJaffray
Reiterated · Overweight · 2015-02-13
—
—
MLV & Co.
Upgraded · Hold → Buy · 2014-11-04
—
—
Leerink Swann
Reiterated · Outperform · 2014-05-19
—
—
Roth Capital
Reiterated · Buy · 2014-03-05
—
—
Dawson James
Reiterated · Market Outperform → Outperform · 2012-11-27
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space